000 01562 a2200433 4500
005 20250513161139.0
264 0 _c19990311
008 199903s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-199901000-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aReilly, M P
245 0 0 _aA randomized, placebo-controlled, crossover study of E5510 and aspirin in healthy volunteers.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cJan 1999
300 _a12-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAspirin
_xpharmacokinetics
650 0 4 _aBleeding Time
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aCross-Over Studies
650 0 4 _aCyclic AMP
_xmetabolism
650 0 4 _aDouble-Blind Method
650 0 4 _aEicosanoids
_xurine
650 0 4 _aFatty Acids, Monounsaturated
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPlatelet Aggregation
_xdrug effects
650 0 4 _aPlatelet Aggregation Inhibitors
_xpharmacokinetics
650 0 4 _aThromboxanes
_xblood
700 1 _aMoran, N
700 1 _aMeagher, E
700 1 _aDelanty, N
700 1 _aCucchiara, A E
700 1 _aLawson, J A
700 1 _aCatella-Lawson, F
773 0 _tJournal of cardiovascular pharmacology
_gvol. 33
_gno. 1
_gp. 12-8
856 4 0 _uhttps://doi.org/10.1097/00005344-199901000-00003
_zAvailable from publisher's website
999 _c9852153
_d9852153